RETRACTED ARTICLE: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy

Table 1 Univariate analysis of clinical and pathological characteristics of 99 PR + breast cancer patients in relation to p-c-Jun and PR colocalization positivity using Odds ratio model

p-c-Jun and PR colocalization
Variable	Characteristics	(−) N = 128	(+) N = 81	OR (Odds ratio)	95% CI (Confidence interval)	P-value
Clinicopathological data
Age (Y)	<50	6	33	0.73	0.2 to 2.3	0.56^a
Age (Y)	>50	12	48	0.73	0.2 to 2.3	0.56^a
Tumor size	<20 mm	1	15	0.25	0.005 to 1.94	0.29^b
Tumor size	>20 mm	17	66	0.25	0.005 to 1.94	0.29^b
Lymph node metastasis	Negative	3	38	0.22	0.04 to 0.9	0.019^b
Lymph node metastasis	Positive	15	43	0.22	0.04 to 0.9	0.019^b
Distant metastasis	M0	17	76	1.1	0.1 to 56	1^b
Distant metastasis	M1	1	5	1.1	0.1 to 56	1^b
Clinical stage	I + II	11	50	0.97	0.3 to 3.3	0.96^a
Clinical stage	III + IV	7	31	0.97	0.3 to 3.3	0.96^a
Tumor grade	Well to moderately differentiated^c	13	68	0.49	0.13 to 2.1	0.3^b
Tumor grade	Poorly differentiated^c	5	13	0.49	0.13 to 2.1	0.3^b
Estrogen receptor (ER)	Negative	1	6	0.74	0.01 to 6.7	1^b
Estrogen receptor (ER)	Positive	17	75	0.74	0.01 to 6.7	1^b

^aχ² Test.
^bFisher’s exact test.
^cWell to moderately differentiated: tumor grade 1 + 2; poorly differentiated: tumor grade 3.

ISSN: 1465-542X